Sykon Capital’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,000
Closed -$15.3K 94
2024
Q2
$15.3K Hold
15,000
0.01% 90
2024
Q1
$27.5K Hold
15,000
0.01% 93
2023
Q4
$18.6K Hold
15,000
0.01% 81
2023
Q3
$17.1K Hold
15,000
0.01% 56
2023
Q2
$13.7K Buy
+15,000
New +$13.7K 0.01% 53